Interferon-α induced Raynaud's syndrome

Annals of Oncology

Volumn 11, Issue 11, 2000, Pages 1501-1502

  Kruit, W H J ^a   Eggermont, A M M ^a   Stoter, G ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

Author keywords

Cytokine; Immunotherapy; Melanoma; Vasospasm

Indexed keywords

ALPHA INTERFERON;

ADJUVANT CHEMOTHERAPY; ADULT; ARTICLE; CASE REPORT; FEMALE; HIGH RISK PATIENT; HUMAN; IMMUNOTHERAPY; MELANOMA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAYNAUD PHENOMENON; SYMPTOM; VASOSPASM; VIRUS HEPATITIS;

EID: 0033636802     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026586629166     Document Type: Article

References (10)

1. Clinical toxicity of the interferons
2. Raynaud's phenomenon and cryoglobulinaemia associated with the use of recombinant human alpha-interferon
3. Digital vasculitis associated with interferon therapy
4. Raynaud's phenomenon associated with alfa-interferon therapy
5. Severe Raynaud's syndrome associated with interferon therapy
6. The Raynaud phenomenon and interferon therapy
7. Syndrome de Raynaud complique de gangrene digitale au cours d'un traitement par l'interferon alpha
8. Interferon-induced vasospasm in chronic myeloid leukemia
9. Interferon-induced coronary vasospasm; a case history
10. Biateral transient visual obscurations with headaches during alpha-II interferon therapy: A case report